Answer:
Taking into account the American guidelines for the treatment of arterial hypersensitive, first line, an inhibitory ACE or an ARA II should be sent. Secondly, a diuretic thiazidic (chlortalidone), third, calcium antagonist or beta blocker, then the treatment is fully personalized.
Answer:
(A) - The volume of the blood plasma increases on overhydration and decreaes on dehydration.
(B) - Osmolality of blood increases with the dehydration and decreases with the overhydration.
Explanation:
If the levels of drinking water is increased, then the plasma becomes more dilute and the plasma volume increases because <u>the water will be reabsorbed more and which as a result reduces plasma concentration of the solutes and increases volume of plasma.</u>
Plasma osmolality measures electrolyte-water balance of the body. <u>As mentioned, above on overhydration, the plasma concentration of the solutes decraeses which also decreases osmolality. So, Osmolality of blood increases with the dehydration and decreases with the overhydration. </u>Increased osmolality in blood stimulate the secretion of antidiuretic hormone which results in the increased water reabsorption and therefore, more concentrated urine and hence blood plasma with less concentration.
Answer:
Affected infants uniformly have significant hypotonia, feeding difficulties, and failure to thrive (FTT), followed in later infancy or early childhood by excessive appetite with gradual development of obesity, short stature and/or decreased growth velocity, intellectual disabilities (average IQ of 65), and behavioral problems (e.g., temper tantrums, outburst, and skin picking
Explanation:
Answer:
Piaget's theory of cognitive development is a comprehensive theory about the nature and development of human intelligence. It was originated by the Swiss developmental psychologist Jean Piaget (1896–1980). ... Piaget's theory is mainly known as a developmental stage theory.
Explanation:
Despite minimal evidence of effectiveness, pancreatic enzyme supplementation is frequently used to relieve pain in people with chronic pancreatitis.
Comparing pancreatic enzyme supplementation to placebo, no improvement in discomfort was seen. The only trial that used enzymes without an enteric coating did indicate a decrease in pain score. In both analyses, there was a significant amount of study heterogeneity. A random model meta-analysis of three studies found no evidence of a difference between the periods of administering pancreatic enzyme supplementation versus placebo in the mean daily pain score (mean difference: 0.09 (1.57-1.39), p=0.91) or average weekly analgesic consumption (mean difference: 0.30 (2.37-1.77), p=0.77). Given their high cost and probable adverse effects, pancreatic enzyme supplements shouldn't be recommended only for treating abdominal pain in people with chronic pancreatitis.
Learn more about chronic pancreatitis here:-
brainly.com/question/13938847
#SPJ4
